相关实验视频

Updated: May 28, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

在骨髓瘤中SETDB1放大:从其在健康组织和其他癌症类型中的作用的见解

Elodie Verdier^1,2, Nathalie Gaspar^1,2, Maria Eugenia Marques Da Costa^1,2

¹UMR 1015 Tumour Immunology and anti-cancer immunotherapy Unit, Gustave Roussy Cancer Campus, Villejuif 94800, France.

|February 13, 2025

概括

含有SET域的蛋白1 (SETDB1) 对于基因沉默至关重要,并与各种癌症有关. 它在骨髓瘤中的作用需要进一步研究潜在的治疗策略.

科学领域:

表观遗传学和癌症生物学
分子瘤学分子瘤学

背景情况:

表观遗传修饰调节基因表达而不改变DNA序列,在癌症发育中至关重要.
SETDB1 (含有SET域的蛋白1) 控制了基因组甲基化 (H3 K9二和三甲基化),促进了基因沉默和异色染色体的形成.
放松SETDB1表达的调节与侵袭性,复发性或耐治疗性癌症亚型有关.

研究的目的:

探索SETDB1在骨髓瘤中扮演的角色,骨髓瘤是一种遗传复杂的肉瘤.
研究SETDB1作为骨髓瘤治疗点的潜力,考虑到其参与骨质母细胞生成和脂肪生成.

主要方法:

审查关于表观遗传修饰和SETDB1.1.的现有文献.
对最近Omics数据的分析表明SETDB1在骨髓瘤中的存在和放大.
讨论SETDB1在细胞分化和癌症进展中的已知功能.

主要成果:

SETDB1在介酶干细胞分化,瘤逃避和治疗耐药性方面发挥着关键作用.
最近的Omics分析表明,在骨髓瘤中SETDB1放大.
已经确定了SETDB1在骨质母细胞生成和脂肪生成中的参与.

结论:

SETDB1在骨髓瘤病变发生中的作用尚未得到充分研究,但遗传数据表明了这一点.
SETDB1在分化中的功能及其与癌症的联系表明它是骨髓瘤的有希望的治疗点.
对骨髓瘤中SETDB1机制的进一步研究对于开发新型治疗策略至关重要.

关键词:

在SETDB1中,我们可以使用SETDB1.癌症表观遗传学癌症表观遗传学在骨髓肉瘤中介酶分化.瘤免疫原性瘤免疫原性

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...